Home › Burkitt-lymfoom › Wisconsin › Milwaukee
Burkitt-lymfoom klinische studies in Milwaukee, WI
16 studies voor Burkitt-lymfoom zoeken deelnemers op locaties in en rond Milwaukee (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
RekruterenFase 2
- Children's Hospital of Wisconsin, Milwaukee
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
RekruterenFase 3
- Medical College of Wisconsin, Milwaukee
Blinatumomab Consolidation in Real World
RekruterenObservatieonderzoekGezonde vrijwilligers welkom
- Medical College of Wisconsin, Milwaukee
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
RekruterenObservatieonderzoek
- Children's Hospital of Wisconsin, Milwaukee
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
RekruterenFase 2
- Medical College of Wisconsin, Milwaukee
- Drexel Town Square Health Center, Oak Creek · 11 mijl verwijderd
- Froedtert and MCW Moorland Reserve Health Center, New Berlin · 11 mijl verwijderd
- en nog 1
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
RekruterenFase 2
- Children's Hospital of Wisconsin, Milwaukee
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
RekruterenFase 3
- Medical College of Wisconsin, Milwaukee
Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)
RekruterenFase 1
- Medical College of Wisconsin, Milwaukee
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
RekruterenFase 2
- Children's Hospital of Wisconsin, Milwaukee
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
RekruterenFase 3
- Children's Hospital of Wisconsin, Milwaukee
AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
RekruterenFase 1/2
- Research Site, Milwaukee
LV20.19 CAR T-Cells in Combination With Pirtobrutinib for Relapsed, Refractory B-cell Malignancies
RekruterenFase 1
- Froedtert & the Medical College of Wisconsin, Milwaukee
MCW Alpha/Beta T-Cell and B-Cell Depletion With Targeted ATG Dosing
Rekruteren
- Children's Wisconsin, Milwaukee
Study of SGR-1505 in Mature B-Cell Neoplasms
RekruterenFase 1
- Medical College of Wisconsin, Milwaukee
Long-term Follow-up Study of Patients Receiving CAR-T Cells
RekruterenObservatieonderzoek
- Froedtert Hospital & Medical College of Wisconsin, Milwaukee
Blinatumomab After TCR Alpha Beta/CD19 Depleted HCT
RekruterenFase 2
- Children's Hospital of Wisconsin, Milwaukee
Burkitt-lymfoom studies in andere steden
- Houston, TX21 studies
- Philadelphia, PA16 studies
- Chicago, IL15 studies
- Cincinnati, OH13 studies
- New York City, NY13 studies
- Atlanta, GA12 studies
- Aurora, CO11 studies
- Seattle, WA11 studies
- Durham, NC10 studies
- Boston, MA10 studies
- Kansas City, MO10 studies
- Los Angeles, CA10 studies
Andere studies in Milwaukee
- Borstkanker23 studies
- Kanker (alle vormen)22 studies
- Niet-kleincellige longkanker22 studies
- Multipel myeloom21 studies
- Longkanker21 studies
- Prostaatkanker20 studies
- Folliculair lymfoom19 studies
- Non-Hodgkinlymfoom18 studies
- Aldermeesklierkanker18 studies
- Acute myeloïde leukemie17 studies
- Eierstokkanker17 studies
- Diffuse groot-B-cel lymfoom16 studies
Van ClinicalTrials.gov, gegevens opgehaald op 6 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.